Healthcare drug diversion programs are often faced with an interesting obstacle: maintaining a balance between accepting accountability and recognizing risk. Due to DEA registration, the
High-profile drug diversion incidents and evolving regulatory compliance underscore the growing emphasis on DEA inspections in healthcare facilities. For pharmacists, nurses, and compliance officers in
The investigative interview presents one of the most significant vulnerabilities in drug diversion prevention. Conducting effective interviews during drug diversion investigations is critical to confirming
The State of Drug Diversion Report in 2025 explores healthcare leaders’ perceptions of drug diversion monitoring programs. Consistent with prior years’ studies, almost all survey